Ruxolitinib In GvHD

Clinical trial NCT02396628 · TERMINATED

Trial details

NCT number: NCT02396628
Sponsor: Prof. Dr. Nikolas von Bubnoff
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Graft vs Host Disease

Start date: 2017-06-29
Primary completion: 2019-11-15
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.